Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × Watchful Waiting × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Uterine Cervical Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Rectal Neoplasms 1 Neuroblastoma 1 Muscle-invasive Bladder Cancer 1 Mouth Neoplasms 1 Mesothelioma, Malignant 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Body Weight Changes 1 Anorexia 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Cisplatin 113 Radiotherapy 71 Cetuximab 68 Docetaxel 50 Paclitaxel 41 pembrolizumab 39 Carboplatin 39 Fluorouracil 38 Radiotherapy, Intensity-Modulated 30 Drug Therapy 15 Radiation 13 Gefitinib 13 Nivolumab 11 Gemcitabine 11 Surgical Procedures, Operative 10 Bevacizumab 10 Amifostine 9 tislelizumab 8 Pemetrexed 8 Oxaliplatin 8 Erlotinib Hydrochloride 8 Celecoxib 8 Capecitabine 8 durvalumab 7 atezolizumab 7 Filgrastim 7 Panitumumab 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06998342 2025-05-31

MOHSAHRTSS

University of Vermont Medical Center

Phase 2 Not yet recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡